207 related articles for article (PubMed ID: 25208121)
81. Tumour imaging with radiolabelled monoclonal antibodies.
Britton KE
Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
[TBL] [Abstract][Full Text] [Related]
82. Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody.
Liu Z; Jin C; Yu Z; Zhang J; Liu Y; Zhao H; Jia B; Wang F
Bioconjug Chem; 2010 Feb; 21(2):314-8. PubMed ID: 20078028
[TBL] [Abstract][Full Text] [Related]
83. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.
Modorati G; Brancato R; Paganelli G; Magnani P; Pavoni R; Fazio F
Br J Ophthalmol; 1994 Jan; 78(1):19-23. PubMed ID: 8110692
[TBL] [Abstract][Full Text] [Related]
84. Tumor detection with 131I-labeled human monoclonal antibody COU-1 in patients with suspected colorectal carcinoma.
Ditzel H; Rasmussen JW; Erb K; Borup-Christensen P; Titlestad I; Lassen E; Fenger C; Kronborg O; Jensenius JC
Cancer Res; 1993 Dec; 53(24):5920-8. PubMed ID: 8261404
[TBL] [Abstract][Full Text] [Related]
85. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Hernández P; Moreno E; Aira LE; Rodríguez PC
Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
[TBL] [Abstract][Full Text] [Related]
86. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
87. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
Quak J; van Dongen G
Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
[TBL] [Abstract][Full Text] [Related]
88. Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodies.
Plaizier MA; Roos JC; Teule GJ; van Dieren EB; den Hollander W; Haisma HJ; DeJager RL; van Lingen A
Eur J Nucl Med; 1994 Mar; 21(3):216-22. PubMed ID: 8200389
[TBL] [Abstract][Full Text] [Related]
89. [Immunoscintigraphy in inflammatory and malignant diseases. anti-leukocyte and anti-tumor antibodies].
Kramer W; Baum RP; Hör G; Jonas D
Urologe A; 1993 Mar; 32(2):108-14. PubMed ID: 8475608
[TBL] [Abstract][Full Text] [Related]
90. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
Britton KE
Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
[TBL] [Abstract][Full Text] [Related]
91. [Immunoscintigraphy in oncology].
Vuillez JP
Rev Med Interne; 1995; 16(11):833-42. PubMed ID: 8570940
[TBL] [Abstract][Full Text] [Related]
92. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
Campobasso N; Dammacco F
Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
[TBL] [Abstract][Full Text] [Related]
93. Current status of therapy of solid tumors.
Jhanwar YS; Divgi C
J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
[TBL] [Abstract][Full Text] [Related]
94. Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer.
Mariani G; Molea N; Bacciardi D; Boggi U; Fornaciari G; Campani D; Salvadori PA; Giulianotti PC; Mosca F; Gold DV
Cancer Res; 1995 Dec; 55(23 Suppl):5911s-5915s. PubMed ID: 7493369
[TBL] [Abstract][Full Text] [Related]
95. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
[TBL] [Abstract][Full Text] [Related]
96. The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.
Han S; Jin G; Wang L; Li M; He C; Guo X; Zhu Q
J Immunol Res; 2014; 2014():268479. PubMed ID: 24818166
[TBL] [Abstract][Full Text] [Related]
97. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
98. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.
Crombet T; Torres O; Rodríguez V; Menéndez A; Stevenson A; Ramos M; Torres F; Figueredo R; Veitía I; Iznaga N; Pérez R; Lage A
Hybridoma; 2001 Apr; 20(2):131-6. PubMed ID: 11394532
[TBL] [Abstract][Full Text] [Related]
99. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Witzig TE; Gordon LI; Cabanillas F; Czuczman MS; Emmanouilides C; Joyce R; Pohlman BL; Bartlett NL; Wiseman GA; Padre N; Grillo-López AJ; Multani P; White CA
J Clin Oncol; 2002 May; 20(10):2453-63. PubMed ID: 12011122
[TBL] [Abstract][Full Text] [Related]
100. Preliminary study on radioimmunodiagnosis of experimental tumor models using technetium-99m-labeled anti-C-erbB-2 monoclonal antibody.
Meenakshi A; Kumar RS; Ganesh V; Kumar NS
Tumori; 2002; 88(6):507-12. PubMed ID: 12597148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
